Hirofumi Hirakawa, MD, PhD

Department of Neuropsychiatry, Oita University Faculty of Medicine, Oita, Japan

  • 6Articles
  • 20.7KReads1
  • 2015–2026Active
  • 10Collaborators
  • 6Citations2

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

About

Hirofumi Hirakawa, MD, PhD, is affiliated with the Department of Neuropsychiatry at Oita University Faculty of Medicine in Japan. Hirakawa has published extensively on topics including neurology, schizophrenia and schizoaffective disorders, cardiology, depression, and seizures. The work covers clinical issues such as hallucinosis related to thalamic lesions, clozapine-induced cardiac effects, medical decision-making competence in schizophrenia, depression's impact on treatment adherence, bright light therapy for negative symptoms, and pharmacological management of aggression in limbic encephalitis. Collaborations frequently include Takeshi Terao, Etsuro Matsubara, Hirotaka Mukasa, Mizuki Kudo, and Nobuyoshi Ishii.

Publications

PCC
Peduncular Hallucinosis With Right Thalamic Cavernous Angioma
PCC
Clozapine-Induced Corrected QT-Interval Prolongation and Relationship With Serum Clozapine Concentration
PCC
Treatment Decision-Making Capacity With the MacCAT-T in Schizophrenia
JCP
PCC
PCC

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.